February 2011

Crack GPAT — Prepare for GPAT Online 
PharmaTutor
12 February 2011

Job in Sahajanand Medical Technologies as Production officer | Freshers

Sahajanand Medical Technologies is a leading developer and manufacturer of minimally invasive coronary stent systems, with one of the broadest product portfolio in the industry. We committed to the welfare of all patients around the world; we shall provide best evidence based products to fight cardiovascular disease. Sahajanand Medical Technologies has a strong international presence and we are proud to be a first company to secure CE mark for biodegradable polymer based Drug Eluting Stents.

12 February 2011
Career opportunity in Novartis for the post of Pharmacovigilance Data Manager

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.

12 February 2011
Work as Regulatory Writers in Cactus Communications

Cactus Communications—a company dedicated to the pursuit of good English. We provide editing, educational, transcription, and training services to individual and institutional clients worldwide. All our businesses are linked together by one common factor—great written English.

12 February 2011
Job opening in Themis Medicare for the post of Hospital Executive - Fresher

Themis Medicare is headquartered in Mumbai with four state-of-the-art manufacturing facilities at three locations, in Vapi (Gujarat), Hyderabad (Andhra Pradesh), and Haridwar (Uttaranchal).

12 February 2011
Novartis drug Afinitor extends progression-free survival in patients with advanced pancreatic neuroendocrine tumors

The New England Journal of Medicine (NEJM) published a study that shows Afinitor® (everolimus) tablets plus best supportive care (BSC) more than doubled progression-free survival (PFS), or time without tumor growth, versus placebo plus BSC in patients with advanced pancreatic neuroendocrine tumors (NET)[1].

12 February 2011
Anesthesiologists Ask FDA to Okay Importation of Sodium Thiopental

The American Society of Anesthesiologists (ASA) has asked the US Food and Drug Administration (FDA), for the sake of patient safety, to work with foreign governments to allow for the importation of sodium thiopental (Pentothal, Hospira) because domestic production of the controversial agent ceased in 2009.

12 February 2011
FDA Adds 13 Drugs to Watch List

The US Food and Drug Administration (FDA) has released its latest list of drugs to monitor based on potential signs of serious risks or new safety information identified in the agency's Adverse Event Reporting System (AERS).

The quarterly watch list consists of 13 medications that treat a wide range of conditions, including cough, angina, diabetes, cancer, and bipolar disorder.

12 February 2011
‘Bangalore India Bio 2011 to be held from May 4-6 at Bangalore Intl Exhibition Centre

Karnataka’s  Department of Information Technology, Bio-Technology and Science & Technology,  Vision Group on Biotechnology and MM Activ Sci-Tech Communications have announced that the 11th edition of the annual  ‘Bangalore India Bio 2011’ will be held from May 4 to May 6, 2011 at the Bangalore International Exhibition Centre (BIEC) on Tumkur Road, Bangalore.

12 February 2011
Researchers from UTHealth & Athersys present data illustrating potential benefits of MultiStem for treating stroke

Medical researchers from The University of Texas Health Science Centre at Houston (UTHealth) presented new research results at the American Heart Association International Stroke Conference that demonstrated how MultiStem, a novel stem cell therapy being developed by Athersys, Inc. provided multiple benefits when administered in preclinical models of ischemic stroke.

11 February 2011
One time Opportunity: Requirement of Fresh Pharmacy candidates in Novartis Pharma

A global healthcare leader, Novartis has one of the most exciting product pipelines in the industry today. A pipeline of innovative medicines brought to life by diverse, talented and performance driven people. All of which makes them one of the most rewarding employers in their field.